Digestive System Neoplasms
Information
- Disease name
- Digestive System Neoplasms
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT05602935 | Active, not recruiting | Phase 2 | Efficacy and Safety of SOX Regimen Combined With Camrelizumab as Neoadjuvant Treatment in Locally Advanced Gastric Cancer: a Phase II, Single-arm Study | September 16, 2020 | December 30, 2026 |
| NCT00392366 | Completed | N/A | Laser Interstitial Thermal Therapy Under "Real Time" MRI Guidance for "Minimal Invasive" Treatment of Liver Metastasis | July 2006 | July 2008 |
| NCT01832116 | Completed | Phase 1 | 89Zr-MMOT PET Imaging in Pancreatic and Ovarian Cancer Patients | March 2013 | May 2014 |
| NCT01964430 | Completed | Phase 3 | Nab-paclitaxel and Gemcitabine vs Gemcitabine Alone as Adjuvant Therapy for Patients With Resected Pancreatic Cancer (the "Apact" Study) | March 28, 2014 | June 30, 2022 |
| NCT01996306 | Completed | Phase 3 | A Phase III Study of 2nd-line XELIRI ± Bevacizumab vs. FOLFIRI ± Bevacizumab in mCRC | December 2, 2013 | June 30, 2018 |
| NCT02781532 | Completed | Evaluation of Predictive Visual Analog Scale (VAS) for Determining the Ingesta of Patients Carrying a Digestive Cancer | April 2014 | January 2015 | |
| NCT02897778 | Completed | Phase 1 | Cardiac Safety Study of Entinostat in Men and Women With Advanced Solid Tumors | August 24, 2016 | March 13, 2017 |
| NCT02909452 | Completed | Phase 1 | Continuation Study of Entinostat in Combination With Pembrolizumab in Patients With Advanced Solid Tumors | September 20, 2016 | February 9, 2021 |
| NCT03072472 | Completed | N/A | BowelScope: Accuracy of Detection Using ENdocuff Optimisation of Mucosal Abnormalities | February 14, 2017 | February 13, 2018 |
| NCT03115957 | Completed | N/A | Early Versus Delayed Parenteral Nutrition in Abdominal Surgical Patients | April 14, 2017 | February 22, 2019 |
| NCT03117348 | Completed | N/A | Gradual Versus Immediate Goal-dose Enteral Nutrition in Abdominal Surgery Patients | April 15, 2017 | February 16, 2019 |
| NCT03717298 | Completed | Phase 2 | Evaluation of Ocoxin-Viusid® in Advanced Pancreatic Adenocarcinoma | October 30, 2018 | January 20, 2023 |
| NCT04080843 | Completed | Phase 2 | Anlotinib Hydrochloride Capsules Combined With CAPEOX in RAS and BRAF Wild-type mCRC Patients | November 15, 2019 | July 1, 2022 |
| NCT04962958 | Not yet recruiting | Phase 2 | Hepatic Artery Infusion Chemotherapy Plus Donafenib in Patients With Hepatocellular Carcinoma After Surgery | July 1, 2023 | August 2024 |
| NCT06026774 | Recruiting | Phase 1 | Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen in Subjects With Resected Digestive System Neoplasms | September 8, 2023 | December 31, 2027 |
| NCT06026800 | Recruiting | Phase 1 | Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen in Combination With Standard First-line Treatment in Subjects With Advanced Digestive System Neoplasms | September 8, 2023 | December 31, 2027 |
| NCT06019702 | Recruiting | Phase 1 | Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen Alone in Subjects With Advanced Digestive System Neoplasms | September 8, 2023 | December 31, 2027 |
| NCT06365866 | Recruiting | N/A | Evaluate the Efficacy of Adding Intraluminal Brachytherapy After CCRT for Local-regional Thoracic Esophageal Cancer. | February 19, 2024 | December 2024 |
| NCT03221335 | Recruiting | N/A | EUS-guided RFA for Solid Abdominal Neoplasms | May 2016 | April 2024 |
| NCT04949282 | Recruiting | Spanish Series of Patients Treated With the Radionuclide Lutetium177 | May 10, 2021 | December 31, 2035 | |
| NCT05624099 | Recruiting | Phase 2 | Camrelizumab Combined With Chemoradiotherapy in Advanced Esophageal Cancer. | August 1, 2023 | December 31, 2027 |
| NCT05913661 | Recruiting | Phase 2 | Pemigatinib Combined With PD-1 Inhibitor in Unresectable or Metastatic Intrahepatic Cholangiocarcinoma | July 2023 | November 2024 |
| NCT05252078 | Recruiting | Phase 2 | Anlotinib Hydrochloride Capsules Combined With TQB2450 Injection in Esophageal Squamous Cell Carcinoma Patients | June 2, 2022 | November 2026 |
| NCT05287165 | Recruiting | Early Phase 1 | Clinical Trial to Evaluate the Safety and Efficacy of IM96 CAR-T Cells Therapy in Patients With Advanced Digestive System Neoplasms | March 10, 2022 | June 30, 2024 |
| NCT01009593 | Terminated | Phase 3 | Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellular Carcinoma (HCC) | January 2010 | July 2012 |
| NCT03681600 | Terminated | Observatory of the Quality of Surgical Procedures for Digestive Cancers | January 1, 2018 | June 30, 2020 | |
| NCT04644315 | Terminated | Phase 2 | A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid Tumors | May 24, 2021 | May 16, 2022 |
| NCT03306693 | Terminated | N/A | Educational Intervention to Increase the Emotional Competence of Patients With Oesogastric and Bronchopulmonary Cancers | October 26, 2017 | May 7, 2019 |
| NCT02005965 | Unknown status | Low Rectal Cancer Study (MERCURY II) | August 13, 2007 | March 11, 2021 | |
| NCT02202928 | Unknown status | Phase 2 | Adoptive Cell Therapy Plus Chemotherapy and Radiation After Surgery in Treating Patients With Colorectal Cancer | July 2014 | December 2017 |
| NCT02208804 | Unknown status | Phase 2/Phase 3 | Surefire Infusion System vs. Standard Microcatheter Use During Holmium-166 Radioembolization | November 2014 | |
| NCT02356406 | Unknown status | Phase 2 | Celiac Plexus Radiosurgery for Pain Management | January 2014 | June 2016 |
| NCT02215837 | Unknown status | Phase 2 | Study of Autologous Tumor Lysate-pulsed D-CIK Combined With Chemotherapy for Gastric Cancer | August 2014 | May 2018 |
| NCT02487017 | Unknown status | Phase 2 | DC-CIK Combined With TACE in the Treatment of Hepatocellular Carcinoma | May 2015 | December 2018 |
| NCT02644863 | Unknown status | Phase 2 | Autologous Tumor Tissue Antigen-sensitized DC-CIK Cells Combined With Chemotherapy for Esophageal Cancer | December 2015 | May 2019 |
| NCT05322486 | Unknown status | Palliative Primary Tumor Resection in Minimally Symptomatic Patients With Colorectal Cancer and Synchronous Unresectable Metastases | October 29, 2020 | December 2022 | |
| NCT03271255 | Unknown status | Phase 2 | Apatinib Versus Bevacizumab in Second-line Therapy for Colorectal Cancer(ABST-C) | May 23, 2018 | December 31, 2022 |
| NCT03303495 | Unknown status | Phase 3 | A Study of 2nd-line FOLFIRI ± Bevacizumab vs. Irinotecan ± Bevacizumab in mCRC | November 14, 2011 | December 31, 2018 |
| NCT03488446 | Unknown status | Radiomics for Prediction of Lymph Node Metastasis in Gastric Cancer（RPLNM）(GIPMCS-1701) | August 30, 2017 | March 31, 2019 | |
| NCT03889626 | Unknown status | Phase 3 | The Maintenance Treatment of Apatinib/Capecitabine Versus Observation in Advanced Gastric Cancer | March 22, 2019 | March 22, 2024 |
| NCT04518852 | Unknown status | Phase 2 | TACE, Sorafenib and PD-1 Monoclonal Antibody in the Treatment of HCC | September 14, 2020 | January 31, 2023 |
| NCT04556344 | Unknown status | N/A | Effectiveness of an Educational Intervention Aimed at Increasing the Emotional Competencies of Patients Under Surveillance After Antineoplastic Treatment of Oesogastric or Bronchopulmonary Cancer | October 26, 2020 | October 2023 |
| NCT04755543 | Unknown status | Phase 1 | A Study of LP002 for the Treatment of Patients With Malignant Digestive System Neoplasms | June 17, 2019 | June 30, 2022 |
| NCT01037049 | Unknown status | Phase 2 | Optimum Timing for Surgery After Pre-operative Radiotherapy 6 vs 12 Weeks | October 16, 2009 | December 8, 2019 |
| NCT01556815 | Unknown status | Phase 2 | Sorafenib Combined With Transarterial Chemoembolization in Treating HBV-infected Patients With Intermediate Hepatocellular Carcinoma | May 2012 | May 2015 |
| NCT01786122 | Unknown status | N/A | Clinical Trial: Effectiveness and Efficiency of Physical Exercise in Cancer Patients | April 2013 | December 2015 |
| NCT01995942 | Unknown status | Molecular, Pathologic and MRI Investigation of the Prognostic and Redictive Importance of Extramural Venous Invasion in Rectal Cancer (MARVEL) Trial | June 7, 2013 | February 2, 2022 |
- MeSH unique ID (MeSH (Medical Subject Headings))
- D004067